Clinical Trials
4 trialsNCT07621471 2026-06-02
IL-15 Enhanced NK Cell Therapy for Solid Tumors
Genovn Therapeutics PTE. LTD.
Phase EARLY_PHASE1 Not yet recruiting
NCT04294875 2024-03-06
MPT0B64
J Ints Bio
Phase EARLY_PHASE1 Withdrawn
NCT04116164 2023-09-25
Safety and Targeting of Anti-hk2 Antibody in mCRPC
SpectronRX
Phase EARLY_PHASE1 Terminated
NCT04674488 2020-12-19
TILs for Treatment of Metastatic or Recurrent Cervical Cancer
Shanghai OriginCell Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Unknown